Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?

被引：0
|
作者：
Hoerl, Walter H. [1 ]
机构：
[1] Dept Med 3, Div Nephrol & Dialysis, A-1090 Vienna, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2009年 / 121卷 / 21-22期
关键词：
HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; DRUG-METABOLISM; WARFARIN; RISK; CYP2C9; MORTALITY; ASSOCIATION; MANAGEMENT; AMERICANS;
D O I：
10.1007/s00508-009-1272-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：668 / 672
页数：5
相关论文
共 50 条
  • [21] ORAL ANTICOAGULATION UNDERUSED AND ASPIRIN OVERUSED FOR ATRIAL FIBRILLATION WITH ADVANCED CHRONIC KIDNEY DISEASE STATUS
    Dorsch, Michael
    Pokorney, Sean
    Birmingham, Mary
    House, John A.
    Moore, Kenneth
    James, Bobbie
    Mashni, Sue
    Thomas, Kevin
    Anstrom, Kevin
    Naccarelli, Gerald
    Berger, Peter
    Fermann, Gregory
    Granger, Christopher B.
    Hylek, Elaine
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 408 - 408
  • [22] Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
    Ozbek, Kerem
    Cicekcioglu, Huelya
    Cetin, Mustafa
    Duyuler, Pinar Turker
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (02): : 266 - 266
  • [23] Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
    Stoica, Mihai Ciprian
    Gall, Zsolt
    Gliga, Mirela Liana
    Caldararu, Carmen Denise
    Szekely, Orsolya
    MEDICINA-LITHUANIA, 2021, 57 (05):
  • [24] Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation
    Stamellou, Eleni
    Floege, Juergen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (10) : 1683 - 1689
  • [25] Oral Anticoagulant Treatment of Atrial Fibrillation in Chronic Kidney Disease Patients
    Artan, Ayse Serra
    Gursu, Meltem
    Elcioglu, Omer Celal
    Kazancioglu, Rumeyza
    TURKISH JOURNAL OF NEPHROLOGY, 2019, 28 (03): : 208 - 215
  • [26] Oral anticoagulation in patients with chronic kidney disease
    Malhotra, Konark
    Ishfaq, Muhammad F.
    Goyal, Nitin
    Katsanos, Aristeidis H.
    Parissis, John
    Alexandrov, Anne W.
    Alexandrov, Andrei V.
    Tsivgoulis, Georgios
    NEUROLOGY, 2019, 92 (21) : E2421 - E2431
  • [27] Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease
    Ballegaard, Ellen Linnea Freese
    Olesen, Jonas Bjerring
    Kamper, Anne-Lise
    Feldt-Rasmussen, Bo
    Gislason, Gunnar
    Torp-Pedersen, Christian
    Carlson, Nicholas
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (02)
  • [28] Uncertainty surrounds anticoagulation risks and benefits in patients with chronic kidney disease with atrial fibrillation
    Massicotte-Azarniouch, David
    Sood, Manish M.
    BMJ EVIDENCE-BASED MEDICINE, 2019, 24 (01) : 35 - 36
  • [29] Anticoagulation in patients with atrial fibrillation and chronic kidney disease: clinical complexity beyond thromboembolism
    Buoninfante, Giovanni
    Basili, Stefania
    Romiti, Giulio Francesco
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (07) : 1797 - 1799
  • [30] Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease
    Garlo, Katherine G.
    Steele, David J. R.
    Nigwekar, Sagar U.
    Chan, Kevin E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (01): : 125 - 136
12345